November 24, 2020
Article
About 20% of 81 positive patients experienced critical neurological complications; further, half had a pre-existing history of high blood pressure or type 2 diabetes.
Guidance based on procalcitonin concentration levels may useful in reducing duration of antibiotic treatment for sickle cell patients with acute chest syndrome.
November 23, 2020
To date, 3 vaccine candidates with favorable safety profiles show promise in offering protection against COVID-19.
The newest indication coincides with growing concerns that COVID-19 and flu spread will cause unprecedented burden on the US this winter.
The AI-based technology is expected to augment telehealth and remote services for a vast majority of cardiological cases.
Telemedicine has been associated with improved access to care and clinical efficiency without sacrificing diagnostic accuracy.
Ongoing debates question whether or not lipid lowering in elderly patients offers similar clinical benefit as in younger patients.
November 22, 2020
The Regeneron monoclonal antibodies are linked to reduced risk of hospitalization or ED visit among mild-to-moderate COVID-19 cases.
An interview with a pain specialist on advancing alternative pain therapy options.
November 20, 2020
Lonafarnib was linked to improved mortality over a maximum of 11 years follow-up, according to supporting data.
